139 related articles for article (PubMed ID: 9702850)
1. Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
Wong SL; O'Dea RF; Dube LM; Awni WM
J Clin Pharmacol; 1998 Jul; 38(7):642-8. PubMed ID: 9702850
[TBL] [Abstract][Full Text] [Related]
2. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
6. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
7. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
Olsson B; Landgren BM
Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers.
Bartoli A; Gatti G; Cipolla G; Barzaghi N; Veliz G; Fattore C; Mumford J; Perucca E
Epilepsia; 1997 Jun; 38(6):702-7. PubMed ID: 9186253
[TBL] [Abstract][Full Text] [Related]
10. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
11. Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
Jacobsen LV; Vouis J; Hindsberger C; Zdravkovic M
J Clin Pharmacol; 2011 Dec; 51(12):1696-703. PubMed ID: 21228406
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
Cawello W; Rosenkranz B; Schmid B; Wierich W
Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
Ragueneau-Majlessi I; Levy RH; Janik F
Epilepsia; 2002 Jul; 43(7):697-702. PubMed ID: 12102671
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
15. Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.
Kothare PA; Seger ME; Northrup J; Mace K; Mitchell MI; Linnebjerg H
BMC Clin Pharmacol; 2012 Mar; 12():8. PubMed ID: 22429273
[TBL] [Abstract][Full Text] [Related]
16. Ziprasidone and the pharmacokinetics of a combined oral contraceptive.
Muirhead GJ; Harness J; Holt PR; Oliver S; Anziano RJ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):49S-56S. PubMed ID: 10771454
[TBL] [Abstract][Full Text] [Related]
17. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Sivasubramanian R; Chakraborty A; Rouzade-Dominguez ML; Neelakantham S; Jakab A; Mensinga T; Legangneux E; Woessner R; Ufer M
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):550-6. PubMed ID: 25943176
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration.
Kives S; Hahn PM; White E; Stanczyk FZ; Reid RL
Contraception; 2005 Mar; 71(3):197-201. PubMed ID: 15722070
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.
Gan L; Jiang X; Mendonza A; Swan T; Reynolds C; Nguyen J; Pal P; Neelakantham S; Dahlke M; Langenickel T; Rajman I; Akahori M; Zhou W; Rebello S; Sunkara G
Clin Pharmacol Drug Dev; 2016 Jan; 5(1):27-39. PubMed ID: 27119576
[TBL] [Abstract][Full Text] [Related]
20. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
